GR3033487T3 - Thiazolidinedione derivatives, their production and use. - Google Patents

Thiazolidinedione derivatives, their production and use.

Info

Publication number
GR3033487T3
GR3033487T3 GR20000401184T GR20000401184T GR3033487T3 GR 3033487 T3 GR3033487 T3 GR 3033487T3 GR 20000401184 T GR20000401184 T GR 20000401184T GR 20000401184 T GR20000401184 T GR 20000401184T GR 3033487 T3 GR3033487 T3 GR 3033487T3
Authority
GR
Greece
Prior art keywords
residue
nitrogen atom
novel
hypolipidemic
atom
Prior art date
Application number
GR20000401184T
Other languages
Greek (el)
English (en)
Inventor
Takashi Sohda
Hitoshi Ikeda
Sachiko Imai
Yu Momose
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of GR3033487T3 publication Critical patent/GR3033487T3/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
GR20000401184T 1992-12-28 2000-05-24 Thiazolidinedione derivatives, their production and use. GR3033487T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP34856892 1992-12-28
JP18099693 1993-07-22

Publications (1)

Publication Number Publication Date
GR3033487T3 true GR3033487T3 (en) 2000-09-29

Family

ID=26500340

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20000401184T GR3033487T3 (en) 1992-12-28 2000-05-24 Thiazolidinedione derivatives, their production and use.

Country Status (21)

Country Link
US (1) US5489602A (cg-RX-API-DMAC7.html)
EP (1) EP0605228B1 (cg-RX-API-DMAC7.html)
JP (1) JP3741452B2 (cg-RX-API-DMAC7.html)
KR (1) KR100292363B1 (cg-RX-API-DMAC7.html)
CN (1) CN1056372C (cg-RX-API-DMAC7.html)
AT (1) ATE190052T1 (cg-RX-API-DMAC7.html)
AU (1) AU666414B2 (cg-RX-API-DMAC7.html)
CA (1) CA2112283A1 (cg-RX-API-DMAC7.html)
CZ (1) CZ288363B6 (cg-RX-API-DMAC7.html)
DE (1) DE69327944T2 (cg-RX-API-DMAC7.html)
DK (1) DK0605228T3 (cg-RX-API-DMAC7.html)
ES (1) ES2142852T3 (cg-RX-API-DMAC7.html)
FI (1) FI935887L (cg-RX-API-DMAC7.html)
GR (1) GR3033487T3 (cg-RX-API-DMAC7.html)
HU (1) HUT69383A (cg-RX-API-DMAC7.html)
MX (1) MX9400190A (cg-RX-API-DMAC7.html)
MY (1) MY110142A (cg-RX-API-DMAC7.html)
NO (1) NO300735B1 (cg-RX-API-DMAC7.html)
PT (1) PT605228E (cg-RX-API-DMAC7.html)
RU (1) RU2129553C1 (cg-RX-API-DMAC7.html)
TW (1) TW245716B (cg-RX-API-DMAC7.html)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL113112A (en) * 1994-03-28 2000-06-01 Nissan Chemical Ind Ltd Pyridine substituted thiazolidinediones and pharmaceutical compositions comprising them
EP0783496B9 (en) * 1994-08-10 2003-09-03 Takeda Chemical Industries, Ltd. Thiazolidinedione derivatives, their production and use
US5641796A (en) * 1994-11-01 1997-06-24 Eli Lilly And Company Oral hypoglycemic agents
US5925656A (en) * 1995-04-10 1999-07-20 Dr. Reddy's Research Foundation Compounds having antidiabetic, hypolipidemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
ZA973850B (en) * 1996-05-06 1997-12-02 Reddy Research Foundation Novel antidiabetic compounds having hypolipidaemic, anti-hypertensive properties, process for their preparation and pharmaceutical compositions containing them.
US5919782A (en) * 1996-05-06 1999-07-06 Dr. Reddy's Research Foundation Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
US5889032A (en) * 1996-05-06 1999-03-30 Dr. Reddy's Research Foundation Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
US5801173A (en) * 1996-05-06 1998-09-01 Dr. Reddy's Research Foundation Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
US6372750B2 (en) 1996-07-01 2002-04-16 Dr. Reddy's Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compounds containing them and their use in the treatment of diabetes and related diseases
USRE39266E1 (en) 1996-07-01 2006-09-05 Dr. Reddy's Laboratories, Limited Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
US5885997A (en) * 1996-07-01 1999-03-23 Dr. Reddy's Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
US6114526A (en) * 1996-07-01 2000-09-05 Dr. Reddy's Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
KR100579765B1 (ko) 1996-07-01 2006-12-28 닥터 레디스 레보러터리즈 리미티드 신규헤테로고리형화합물의제조방법,이를함유하는약제조성물및당뇨병및이와관련된질병의치료에있어서그의용도
CN1221417A (zh) * 1996-07-26 1999-06-30 雷迪博士研究基金会 具有抗糖尿病、降低血脂、抗高血压性能的噻唑烷二酮化合物,其制备方法及其药物组合物
DE69723869T2 (de) * 1996-12-31 2004-04-22 Dr. Reddy's Laboratories Ltd. Heterozyklische verbindungen, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen die diese enthalten und ihre anwendung in der behandlung von diabetis und verwandten krankheiten
TW577875B (en) * 1997-01-31 2004-03-01 Shionogi & Co Pyrrolidine derivatives with inhibitory activity for phospholipase A2
JP2001518069A (ja) * 1997-05-02 2001-10-09 ドクター・レディーズ・リサーチ・ファウンデーション 低脂質性、抗高血圧性特性を有する新規な抗糖尿病化合物、それらの製造方法及びそれらを含有する薬学的組成物
GB9726568D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
IL143299A0 (en) * 1998-12-01 2002-04-21 Novo Nordisk As Pharmaceutical composition comprising 5-[[4- [3-methyl-4-oxo-3, 4-dihydro-2-quinazolinyl] methoxy] phenyl-methyl] thiadiazolidine-2, 4-dione and the process for its preparation
JP4316787B2 (ja) * 2000-01-11 2009-08-19 壽製薬株式会社 エーテル又はアミド誘導体、その製法並びにそれを含有する糖尿病治療剤、
US20030212138A1 (en) * 2002-01-14 2003-11-13 Pharmacia Corporation Combinations of peroxisome proliferator-activated receptor-alpha agonists and cyclooxygenase-2 selective inhibitors and therapeutic uses therefor
US20030220374A1 (en) * 2002-01-14 2003-11-27 Pharmacia Corporation Compositions and methods of treatment involving peroxisome proliferator-activated receptor-gamma agonists and cyclooxygenase-2 selective inhibitors
WO2004100895A2 (en) * 2003-05-13 2004-11-25 Pharmacia Corporation Compositions of a cyclooxygenase-2 selective inhibitor and a peroxisome proliferator activated receptor agonist for the treatment of ischemic mediated central nervous system disorders
US7833513B2 (en) 2004-12-03 2010-11-16 Rhode Island Hospital Treatment of Alzheimer's Disease
WO2011079274A1 (en) * 2009-12-23 2011-06-30 Jasco Pharmaceuticals, LLC Aminopyrimidine kinase inhibitors
CN101824032B (zh) * 2010-04-23 2015-09-09 浙江华海药业股份有限公司 一种制备盐酸吡格列酮的工艺改进方法
BR112014010563B1 (pt) 2011-11-04 2021-01-12 Jasco Pharmaceuticals, LLC compostos inibidores da aminopirimidina quinase

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5364586A (en) * 1976-11-19 1978-06-09 Takeda Chemical Industries Ltd Emission driving device for blood detector
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
JPS5564586A (en) * 1978-11-09 1980-05-15 Takeda Chem Ind Ltd Thiazolidine derivative
US4296237A (en) * 1979-09-11 1981-10-20 Merck & Co., Inc. 4-(Pyridyl, piperazinyl and thiazolyl substituted thiazolyl)-3-hydroxy-3-pyrroline-2,5-diones
CA1206151A (en) * 1981-12-28 1986-06-17 Richard P. Pioch Pyrimidone anti-ulcer agents
CN1003445B (zh) * 1984-10-03 1989-03-01 武田药品工业株式会社 噻唑烷二酮衍生物,其制备方法和用途
WO1986006069A1 (fr) * 1985-04-09 1986-10-23 Takeda Chemical Industries, Ltd. Derives de thiazolidinedione, leur procede de preparation et composition medicinale les contenant
JPH06779B2 (ja) * 1985-06-10 1994-01-05 武田薬品工業株式会社 チアゾリジオン誘導体およびそれを含んでなる医薬組成物
US5130379A (en) * 1988-03-08 1992-07-14 Pfizer Inc. Hypoglycemic thiazolidinedione derivatives
MX15171A (es) * 1988-03-08 1993-05-01 Pfizer Derivados de tiazolidinodiona hipoglicemicos
US5143930A (en) * 1990-02-07 1992-09-01 Sankyo Company, Limited Thiazolidine derivatives with anti-diabetic activity, their preparation and their use
RU2066322C1 (ru) * 1991-06-28 1996-09-10 Киевский Государственный Университет Им.Т.Г.Шевченко 3-(4-метил-2-тиазолил)-6-пропил-7-(1-метил-1-этоксикарбонил)метоксихромон, обладающий гипогликемическим, гиполипидемическим действием и аналептическим действием

Also Published As

Publication number Publication date
FI935887A7 (fi) 1994-06-29
HUT69383A (en) 1995-09-28
FI935887A0 (fi) 1993-12-27
JP3741452B2 (ja) 2006-02-01
US5489602A (en) 1996-02-06
NO300735B1 (no) 1997-07-14
CA2112283A1 (en) 1994-06-29
HU9303757D0 (en) 1994-04-28
CN1056372C (zh) 2000-09-13
ATE190052T1 (de) 2000-03-15
DE69327944T2 (de) 2000-10-19
AU666414B2 (en) 1996-02-08
PT605228E (pt) 2000-06-30
CZ288363B6 (en) 2001-06-13
NO934833D0 (no) 1993-12-27
KR940014392A (ko) 1994-07-18
NO934833L (no) 1994-06-29
JPH0782269A (ja) 1995-03-28
CN1094726A (zh) 1994-11-09
KR100292363B1 (ko) 2001-09-17
CZ287693A3 (en) 1994-12-15
EP0605228B1 (en) 2000-03-01
TW245716B (cg-RX-API-DMAC7.html) 1995-04-21
MY110142A (en) 1998-02-28
AU5261393A (en) 1994-07-07
DE69327944D1 (de) 2000-04-06
MX9400190A (es) 1994-07-29
DK0605228T3 (da) 2000-06-05
EP0605228A1 (en) 1994-07-06
ES2142852T3 (es) 2000-05-01
FI935887L (fi) 1994-06-29
RU2129553C1 (ru) 1999-04-27

Similar Documents

Publication Publication Date Title
GR3033487T3 (en) Thiazolidinedione derivatives, their production and use.
NO20001816D0 (no) Substituerte, kondenserte heterosykliske forbindelser
MY141468A (en) 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity
DE3773546D1 (de) Naphthalenderivate, ihr herstellungsverfahren und diese enthaltende pharmazeutische zusammensetzungen.
AU652981B2 (en) Condensed benzoxa ring compound, production thereof, and pharmaceutical composition containing the same
HUS1600015I1 (hu) Eljárás 2-alkil-3-aminotiofén-származékok elõállítására és új 3-aminotiofén-származékok
ATE271045T1 (de) Sauerstoffhaltige heterocyclische verbindungen
DE69430348D1 (de) Oxazolidinedion-Derivate und ihre Anwendung als hypoglykämisches Mittel
DE69432542D1 (de) Tetraderivate, ihre Herstellung und Verwendung
WO2003048130A3 (en) Peroxisome proliferator activated receptor agonists
ID24846A (id) Turunan-turunan bifenilamidina
AU755654C (en) Novel amide compounds and drugs containing the same
KR970707122A (ko) 퀴놀린 유도체(quinoline derivative)
AU2148595A (en) 4,6-di-t-butyl-2,3-dihydrobenzothiophene derivative
PH30229A (en) Pyridyl substituted benzothiazole compounds which has useful pharmaceutical utility
AU6595000A (en) Dihydrobenzofuran derivatives, process for the preparation thereof and agents
MXPA04000620A (es) Uso de derivados de tiazol para elaboracion de medicamento para tratamiento de enfermedad pulmonar obstructiva cronica.
PL342826A1 (en) Derivatives of cycloalkenes, their production and application

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees